Acknowledgement
This study was supported by an Asan Institute for Life Sciences Grant (2022IP0076, 2022IL0035) from Asan Medical Center, Seoul, Republic of Korea, and by the Basic Science Research Program through a National Research Foundation of Korea (NRF) grant of the Korean government (MSIT) (No. 2020R1A4A4078907).
References
- Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3, 1-21 https://doi.org/10.1038/nrdp.2017.13
- Fabbrini G, Brotchie JM, Grandas F, Nomoto M and Goetz CG (2007) Levodopa-induced dyskinesias. Mov Disord 22, 1379-1389 https://doi.org/10.1002/mds.21475
- Benabid AL (2003) Deep brain stimulation for Parkinson's disease. Curr Opin Neurobiol 13, 696-706 https://doi.org/10.1016/j.conb.2003.11.001
- Kalia LV, Kalia SK and Lang AE (2015) Disease-modifying strategies for Parkinson's disease. Mov Disord 30, 1442-1450 https://doi.org/10.1002/mds.26354
- Lotharius J and Brundin P (2002) Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3, 932-942 https://doi.org/10.1038/nrn983
- Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53, S26-S38 https://doi.org/10.1002/ana.10483
- Lee BC, Lee JY, Kim J et al (2020) Graphene quantum dots as anti-inflammatory therapy for colitis. Sci Adv 6, eaaz2630
- Han J, Kim YS, Lim MY et al (2018) Dual roles of graphene oxide to attenuate inflammation and elicit timely polarization of macrophage phenotypes for cardiac repair. Acs Nano 12, 1959-1977 https://doi.org/10.1021/acsnano.7b09107
- Bacon M, Bradley SJ and Nann T (2014) Graphene quantum dots. Part Part Syst Charact 31, 415-428 https://doi.org/10.1002/ppsc.201300252
- Kim D, Yoo JM, Hwang H et al (2018) Graphene quantum dots prevent alpha-synucleinopathy in Parkinson's disease. Nat Nanotechnol 13, 812-818 https://doi.org/10.1038/s41565-018-0179-y
- Jeong JK, Lee YJ, Jeong SY, Jeong S, Lee GW and Park SY (2017) Autophagic flux induced by graphene oxide has a neuroprotective effect against human prion protein fragments. Int J Nanomedicine 12, 8143
- Xiaoli F, Yaqing Z, Ruhui L et al (2021) Graphene oxide disrupted mitochondrial homeostasis through inducing intracellular redox deviation and autophagy-lysosomal network dysfunction in SH-SY5Y cells. J Hazard Mater 416, 126158
- Lee BC, Lee JY, Kim J et al (2020) Graphene quantum dots as anti-inflammatory therapy for colitis. Sci Adv 6, eaaz2630
- Ma J, Liu R, Wang X et al (2015) Crucial role of lateral size for graphene oxide in activating macrophages and stimulating pro-inflammatory responses in cells and animals. ACS Nano 9, 10498-10515 https://doi.org/10.1021/acsnano.5b04751
- Yue H, Wei W, Yue Z et al (2012) The role of the lateral dimension of graphene oxide in the regulation of cellular responses. Biomaterials 33, 4013-4021 https://doi.org/10.1016/j.biomaterials.2012.02.021
- Markovic ZM, Jovanovic SP, Maskovic PZ et al (2019) Graphene oxide size and structure pro-oxidant and antioxidant activity and photoinduced cytotoxicity relation on three cancer cell lines. J Photochem Photobiol B 200, 111647
- Guo S, Bezard E and Zhao B (2005) Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol Med 39, 682-695 https://doi.org/10.1016/j.freeradbiomed.2005.04.022
- Shahriar SMS, Nafiujjaman M, An JM et al (2022) Graphene: a promising theranostic agent. Adv Exp Med Biol 1351, 149-176 https://doi.org/10.1007/978-981-16-4923-3_8
- Huang C, Wu J, Jiang W, Liu R, Li Z and Luan Y (2018) Amphiphilic prodrug-decorated graphene oxide as a multifunctional drug delivery system for efficient cancer therapy. Mater Sci Eng C Mater Biol Appl 89, 15-24 https://doi.org/10.1016/j.msec.2018.03.017
- Jiang W, Chen J, Gong C, Wang Y, Gao Y and Yuan Y (2020) Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy. J Nanobiotechnology 18, 50
- Tabish TA and Narayan RJ (2021) Crossing the bloodbrain barrier with graphene nanostructures. Mater Today 51, 393-401 https://doi.org/10.1016/j.mattod.2021.08.013
- Mittal M, Siddiqui MR, Tran K, Reddy SP and Malik AB (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20, 1126-1167 https://doi.org/10.1089/ars.2012.5149
- Moore DJ, West AB, Dawson VL and Dawson TM (2005) Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28, 57-87 https://doi.org/10.1146/annurev.neuro.28.061604.135718
- Ren C, Hu X and Zhou Q (2018) Graphene oxide quantum dots reduce oxidative stress and inhibit neurotoxicity in vitro and in vivo through catalase-like activity and metabolic regulation. Adv Sci (Weinh) 5, 1700595
- Srikanth K, Sundar LS, Pereira E and Duarte AC (2018) Graphene oxide induces cytotoxicity and oxidative stress in bluegill sunfish cells. J Appl Toxicol 38, 504-513 https://doi.org/10.1002/jat.3557
- Nanda SS, An SSA and Yi DK (2015) Oxidative stress and antibacterial properties of a graphene oxide-cystamine nanohybrid. Int J Nanomedicine 10, 549
- Wang A, Pu K, Dong B et al (2013) Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells. J Appl Toxicol 33, 1156-1164 https://doi.org/10.1002/jat.2877
- Elkon H, Melamed E and Offen D (2004) Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease. J Mol Neurosci 24, 387-400 https://doi.org/10.1385/JMN:24:3:387
- Xicoy H, Wieringa B and Martens GJ (2017) The SH-SY5Y cell line in Parkinson's disease research: a systematic review. Mol Neurodegener 12, 10
- Schober A (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318, 215-224 https://doi.org/10.1007/s00441-004-0938-y
- Olsson M, Nikkhah G, Bentlage C and Bjorklund A (1995) Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 15, 3863-3875 https://doi.org/10.1523/JNEUROSCI.15-05-03863.1995
- Miyanishi K, Choudhury ME, Watanabe M et al (2019) Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson's disease model. Neurochem Int 122, 38-46 https://doi.org/10.1016/j.neuint.2018.11.005
- Mahmoudi M, Akhavan O, Ghavami M, Rezaee F and Ghiasi SM (2012) Graphene oxide strongly inhibits amyloid beta fibrillation. Nanoscale 4, 7322-7325 https://doi.org/10.1039/c2nr31657a
- Ghaeidamini M, Bernson D, Sasanian N, Kumar R and Esbjorner EK (2020) Graphene oxide sheets and quantum dots inhibit alpha-synuclein amyloid formation by different mechanisms. Nanoscale 12, 19450-19460 https://doi.org/10.1039/d0nr05003b
- Alimohammadi E, Khedri M, Miri Jahromi A, Maleki R and Rezaian M (2020) Graphene-based nanoparticles as potential treatment options for Parkinson's disease: a molecular dynamics study. Int J Nanomedicine 15, 6887-6903 https://doi.org/10.2147/IJN.S265140
- Park WK, Kim H, Kim T et al (2015) Facile synthesis of graphene oxide in a Couette-Taylor flow reactor. Carbon 83, 217-223 https://doi.org/10.1016/j.carbon.2014.11.024